# Organogenesis clinical trials: 27 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 27 trials with Organogenesis as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Organogenesis: 27 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/organogenesis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 27
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 27, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| April 3, 2026 | NCT07510412 | Clinical Trial Evaluating NuShield® Plus Standard of Care (SOC) Versus Standard of Care (SOC) Alone in the Management of Non-Healing Venous... | Organogenesis | Not applicable | Recruiting | Venous Leg Ulcers | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07510412) |
| October 1, 2024 | NCT06618612 | A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial... | Organogenesis | Not applicable | Recruiting | Diabetic Foot Ulcer | 170 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06618612) |
| August 21, 2023 | NCT06000410 | A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee | Organogenesis | Phase 3 | Completed | Knee Osteoarthritis | 594 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06000410) |
| May 25, 2021 | NCT04901013 | Clinical Study Of Affinity Versus SOC In The Management Of VLUs | Organogenesis | Not applicable | Unknown | Venous Leg Ulcer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04901013) |
| November 19, 2020 | NCT04636229 | Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee | Organogenesis | Phase 3 | Completed | Knee Osteoarthritis | 516 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04636229) |
| February 26, 2019 | NCT03855514 | Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers | Organogenesis | Not applicable | Unknown | Diabetic Foot Ulcer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03855514) |
| April 19, 2018 | NCT03502824 | PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Management of Stage II-IV Pressure Ulcers. | Organogenesis | Not applicable | Terminated | Chronic Pressure Ulcers | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03502824) |
| September 18, 2017 | NCT03286452 | The RESPOND Registry | Organogenesis | Observational | Completed | Partial Thickness Wound, Pressure Ulcer, Venous Ulcer, Diabetic Ulcer, Surgical Wounds, Trauma Wounds, Draining Wounds... | 310 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03286452) |
| July 2, 2017 | NCT03205436 | Affinity Prospective Diabetic Foot Trial Crossover Group | Organogenesis | Not applicable | Completed | Diabetic Foot Ulcer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03205436) |
| March 6, 2017 | NCT03070938 | PuraPly™ Antimicrobial Wound Matrix and Wound Management | Organogenesis | Observational | Completed | Pressure Ulcer, Venous Ulcer, Diabetic Ulcer, Surgical Wound, Trauma Wound | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03070938) |
| March 6, 2017 | NCT03070925 | Prospective PuraPly™ AM Case Series Study | Organogenesis | Observational | Completed | Pressure Ulcers, Venous Ulcers, Diabetic Ulcers, Surgical Wounds, Trauma Wounds | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03070925) |
| August 26, 2016 | NCT02880592 | Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers | Organogenesis | Not applicable | Completed | Diabetic Foot Ulcers | 89 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02880592) |
| June 21, 2016 | NCT02808234 | Study of Nucel for One and Two Level Lumbar Interbody Fusion | Organogenesis | Not applicable | Unknown | Degenerative Disc Disease, Spondylolisthesis, Spondylosis | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02808234) |
| December 13, 2013 | NCT02011724 | A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf® | Organogenesis | Phase 4 | Unknown | Venous Leg Ulcers | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02011724) |
| August 28, 2013 | NCT01929954 | Safety Study of Gintuit™ in Subjects Requiring Socket Grafting | Organogenesis | Phase 1/2 | Terminated | Edentulous Alveolar Ridge | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01929954) |
| March 8, 2012 | NCT01547962 | A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached Gingiva | Organogenesis | Not applicable | Completed | Gingival Recession | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01547962) |
| April 4, 2011 | NCT01327937 | A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers | Organogenesis | Phase 4 | Completed | Venous Ulcer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01327937) |
| February 9, 2011 | NCT01292122 | Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds | Organogenesis | Not applicable | Terminated | Wounds | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01292122) |
| August 13, 2010 | NCT01181453 | Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers | Organogenesis | Phase 3 | Completed | Diabetic Foot Ulcer | 314 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01181453) |
| August 13, 2010 | NCT01181440 | Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers | Organogenesis | Phase 3 | Completed | Diabetic Foot Ulcer | 281 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01181440) |
| May 29, 2009 | NCT00909870 | Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers | Organogenesis | Phase 3 | Completed | Venous Leg Ulcer | 537 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00909870) |
| May 16, 2008 | NCT00679081 | A Pilot Study of CelTx(TM) (Apligraf®) in the Treatment of Gingival Recession Requiring Root Coverage | Organogenesis | Phase 1/2 | Terminated | Gingival Recession | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00679081) |
| April 1, 2008 | NCT00648674 | A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers | Organogenesis | Phase 4 | Withdrawn | Varicose Ulcer | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00648674) |
| January 7, 2008 | NCT00587834 | Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue Regeneration | Organogenesis | Phase 3 | Completed | Gingival Recession | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00587834) |
| January 7, 2008 | NCT00587587 | A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids | Organogenesis | Phase 1/2 | Completed | Keloid | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00587587) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1/2 | 3 |
| Phase 3 | 8 |
| Phase 4 | 3 |
| Not applicable | 10 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 14 |
| Terminated | 6 |
| Unknown | 4 |
| Recruiting | 2 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetic Foot | 7 |
| Varicose Ulcer | 7 |
| Pressure Ulcer | 4 |
| Surgical Wound | 3 |
| Gingival Recession | 3 |
| Osteoarthritis, Knee | 2 |
| Osteoarthritis | 2 |
| Arthritis | 2 |
| Joint Diseases | 2 |
| Musculoskeletal Diseases | 2 |
| Rheumatic Diseases | 2 |
| Wounds and Injuries | 1 |
| Epidermolysis Bullosa, Junctional | 1 |
| Epidermolysis Bullosa Dystrophica | 1 |
| Intervertebral Disc Degeneration | 1 |
| Spondylolisthesis | 1 |
| Spondylosis | 1 |
| Keloid | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Thai restaurants in the United States](https://specstream.ai/data/businesses/thai-restaurants/united-states)
- [Natural gas utilities in the United States](https://specstream.ai/data/businesses/natural-gas-utilities/united-states)
- [Farm equipment repair companies in the United States](https://specstream.ai/data/businesses/farm-equipment-repair-companies/united-states)
- [B2B power plants and power plant companies in the United States](https://specstream.ai/data/businesses/b2b-power-plants-and-power-plant-companies/united-states)
- [Shared office spaces in the United States](https://specstream.ai/data/businesses/shared-office-spaces/united-states)
- [Law firms in the United States](https://specstream.ai/data/businesses/law-firms/united-states)
